Singapore markets closed

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.0700+0.0300 (+1.47%)
At close: 04:00PM EDT
2.0800 +0.01 (+0.48%)
After hours: 07:37PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
102,891
63,547
417,195
541,158
Other short-term investments
14,857
128,134
0
-
Total cash
117,748
191,681
417,195
541,158
Net receivables
260,522
109,964
123,022
157,046
Inventory
62,605
38,791
37,642
44,233
Other current assets
11,099
22,918
10,798
-
Total current assets
475,631
381,234
602,323
767,479
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
25,770
28,911
24,662
26,158
Accumulated depreciation
-20,651
-20,157
-16,849
-16,050
Net property, plant and equipment
5,119
8,754
7,813
10,108
Goodwill
943
943
943
943
Intangible assets
70,730
4,988
2,620
2,620
Other long-term assets
77,181
84,928
65,635
60,499
Total non-current assets
153,973
99,613
77,011
74,170
Total assets
629,604
480,847
679,334
841,649
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
35,219
11,526
16,159
15,201
Accrued liabilities
272,886
100,240
123,662
105,076
Other current liabilities
-
-
-
3,861
Total current liabilities
331,771
138,694
165,327
145,653
Non-current liabilities
Long-term debt
473,369
471,058
408,280
404,023
Deferred tax liabilities
1,102
0
-
-
Other long-term liabilities
11,459
3,467
750
1,051
Total non-current liabilities
491,258
479,571
416,281
415,022
Total liabilities
823,029
618,265
581,608
560,675
Stockholders' equity
Common stock
11
8
7
7
Retained earnings
-1,579,500
-1,341,608
-1,049,854
-762,754
Accumulated other comprehensive income
-248
-249
-270
-270
Total stockholders' equity
-193,425
-137,418
97,726
280,974
Total liabilities and stockholders' equity
629,604
480,847
679,334
841,649